9th Conference on Biosimilars & Biobetters

Copthorne Tara Hotel, London, UK (September, 26 - 27, 2018)

SMi presents the 9th Conference on Biosimilars & Biobetters

Forecasting the next wave of biosimilars to ensure optimal market commercialisation

Conference:  Wednesday 26 and Thursday 27 September 2018

Location: Copthorne Tara Hotel, London, UK

Website: www.biosimilars-europe.com/gate2biotech

The SMi Group are thrilled to present the 9th annual conference on Biosimilars & Biobetters, taking place on 26th & 27th September in Central London, UK. Following the success of our previous events in both London and the US, Biosimilars and Biobetters UK 2018 will deliver a stellar speaker line-up and bring together a global audience of biosimilar experts to discuss the latest developments and future of the rapidly evolving and expanding biosimilars market.

After over a decade, the biosimilars industry is finally reaching a stage where key stakeholders understand and accept biosimilars. This is reflected in more tolerant legislation and an increased uptake of biosimilars across the globe.

We are now entering a very exciting time, for over the next few years several originator patents are expiring, and we will see the next few waves of biosimilars enter the market. Will the biosimilar be a successful contender and spark a competitive environment or the originator dominate? Have we done enough to convince the payer, prescriber and patient to switch?

WHO SHOULD ATTEND

Chief Executives, Vice Presidents, Executive Directors, Directors, Heads, Managers and Specialists from the following, but not limited to, sectors should attend:

• Biosimilars / Biologics
• Biopharmaceuticals
• Research and Development
• Legal Affairs
• Intellectual Property
• Regulatory Compliance
• Quality affairs and control
• Pharmacovigilance, Drug Safety and Risk Management
• Business Development
• Commercialisation
• Marketing and sales

Join us to hear experiences of key opinion leaders and evaluate market access, opportunities and commercialisation strategies with industry-thought experts.

This event is CPD accredited.

#SMiBiosimilars